iNOS Activity Is Required for the Therapeutic Effect of Mesenchymal Stem Cells in Experimental Systemic Sclerosis

Objectives: Fibrosis is a hallmark of systemic sclerosis (SSc), an intractable disease where innovative strategies are still being sought. Among novel anti-fibrotic approaches, mesenchymal stromal/stem cell (MSC)-based therapy appears promising. Previously, we reported anti-fibrotic effects of MSC i...

Descripción completa

Detalles Bibliográficos
Autores principales: Maria, Alexandre T. J., Rozier, Pauline, Fonteneau, Guillaume, Sutra, Thibault, Maumus, Marie, Toupet, Karine, Cristol, Jean-Paul, Jorgensen, Christian, Guilpain, Philippe, Noël, Danièle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308989/
https://www.ncbi.nlm.nih.gov/pubmed/30622540
http://dx.doi.org/10.3389/fimmu.2018.03056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308989/
https://www.ncbi.nlm.nih.gov/pubmed/30622540
http://dx.doi.org/10.3389/fimmu.2018.03056

Ejemplares similares